Literature DB >> 21649731

Validation study of the Leeds Dyspepsia Questionnaire in a multi-ethnic Asian population.

Sanjiv Mahadeva1, Wah-Kheong Chan, Mohammed Mohazmi, Ramanujam Sujarita, Khean-Lee Goh.   

Abstract

BACKGROUND AND AIM: Outcome measures for clinical trials in dyspepsia require an assessment of symptom response. There is a lack of validated instruments assessing dyspepsia symptoms in the Asian region. We aimed to translate and validate the Leeds Dyspepsia Questionnaire (LDQ) in a multi-ethnic Asian population.
METHODS: A Malay and culturally adapted English version of the LDQ were developed according to established protocols. Psychometric evaluation was performed by assessing the validity, internal consistency, test-retest reliability and responsiveness of the instruments in both primary and secondary care patients.
RESULTS: Between April and September 2010, both Malay (n=166) and Malaysian English (n=154) versions were assessed in primary and secondary care patients. Both language versions were found to be reliable (internal consistency was 0.80 and 0.74 (Cronbach's α) for Malay and English, respectively; spearman's correlation coefficient for test-retest reliability was 0.98 for both versions), valid (area under receiver operating curve for accuracy of diagnosing dyspepsia was 0.71 and 0.77 for Malay and English versions, respectively), discriminative (median LDQ score discriminated between primary and secondary care patients in Malay (11.0 vs 20.0, P<0.0001) and English (10.0 vs 14.0, P=0.001), and responsive (median LDQ score reduced after treatment in Malay (17.0 to 14.0, P=0.08) and English (18.0 to 11.0, P=0.008) to dyspepsia.
CONCLUSIONS: The Malaysian versions of the LDQ are valid, reliable and responsive instruments for assessing symptoms in a multi-ethnic Asian population with dyspepsia.
© 2011 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21649731     DOI: 10.1111/j.1440-1746.2011.06806.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  6 in total

1.  Clinically significant endoscopic findings in a multi-ethnic population with uninvestigated dyspepsia.

Authors:  Sanjiv Mahadeva; Khean-Lee Goh
Journal:  Dig Dis Sci       Date:  2012-06-12       Impact factor: 3.199

2.  Validity and Reliability of the Persian Version of Leeds Dyspepsia Questionnaire.

Authors:  Sepideh Batebi; Abbas Masjedi Arani; Mahdi Jafari; Amir Sadeghi; Mohsen Saberi Isfeedvajani; Mohammad Hassan Davazdah Emami
Journal:  Galen Med J       Date:  2019-12-31

3.  The impact of dyspepsia on symptom severity and quality of life in adults with headache.

Authors:  Mei-Ling Sharon Tai; Norbelinda Norhatta; Khean Jin Goh; Foong Ming Moy; Ramanujam Sujarita; Azman Ahmad Asraff; Qin Zhi Lee; Jiun Hoong Ng; Eugene Choon Li Tan; Sanjiv Mahadeva
Journal:  PLoS One       Date:  2015-01-28       Impact factor: 3.240

4.  Prevalence and sociodemographic determinants of dyspepsia in the general population of Rwanda.

Authors:  Jean Bosco Bangamwabo; John David Chetwood; Vincent Dusabejambo; Cyprien Ntirenganya; George Nuki; Arcade Nkurunziza; Kelly A Kieffer; Michael Jones; Timothy D Walker
Journal:  BMJ Open Gastroenterol       Date:  2020-05

5.  Validation of the Kinyarwanda-version Short-Form Leeds Dyspepsia Questionnaire and Short-Form Nepean Dyspepsia Index to assess dyspepsia prevalence and quality-of-life impact in Rwanda.

Authors:  Arcade Nkurunziza; Vincent Dusabejambo; Kelly Everhart; Steve Bensen; Tim Walker
Journal:  BMJ Open       Date:  2016-06-06       Impact factor: 2.692

6.  High Prevalence of Strongyloides among South Asian Migrants in Primary Care-Associations with Eosinophilia and Gastrointestinal Symptoms.

Authors:  Elinor Chloe Baker; Damien K Ming; Yasmin Choudhury; Shahedur Rahman; Philip J Smith; Jose Muñoz; Peter L Chiodini; Chris J Griffiths; Christopher Jm Whitty; Michael Brown
Journal:  Pathogens       Date:  2020-02-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.